Search hospitals > Illinois > Geneva
Northwestern Medicine Cancer Center Delnor
Claim this profileGeneva, Illinois 60134
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
Conducts research for Lung Cancer
174 reported clinical trials
47 medical researchers
Summary
Northwestern Medicine Cancer Center Delnor is a medical facility located in Geneva, Illinois. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Recurrence, Lung Cancer and other specialties. Northwestern Medicine Cancer Center Delnor is involved with conducting 174 clinical trials across 363 conditions. There are 47 research doctors associated with this hospital, such as Aparna Kalyan, Sunandana Chandra, Devalingam Mahalingam, MBBChBAO, and Seth M. Pollack.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Aparna KalyanNorthwestern University1 year of reported clinical research
Expert in Cancer
Studies Bile Duct Cancer
20 reported clinical trials
39 drugs studied
Sunandana ChandraNorthwestern University1 year of reported clinical research
Expert in Melanoma
Expert in Skin Cancer
22 reported clinical trials
31 drugs studied
Devalingam Mahalingam, MBBChBAONorthwestern University5 years of reported clinical research
Studies Solid Tumors
Studies Tumors
17 reported clinical trials
53 drugs studied
Seth M. PollackNorthwestern University1 year of reported clinical research
Studies Sarcoma
Studies Soft Tissue Sarcoma
16 reported clinical trials
26 drugs studied
Clinical Trials running at Northwestern Medicine Cancer Center Delnor
Breast Cancer
Esophageal Adenocarcinoma
Prostate Cancer
Gastroesophageal Junction Adenocarcinoma
Cancer
Esophageal Carcinoma
Lung Cancer
Renal Cell Carcinoma
Non-Small Cell Lung Cancer
Diffuse Large B-Cell Lymphoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Northwestern Medicine Cancer Center Delnor?
Northwestern Medicine Cancer Center Delnor is a medical facility located in Geneva, Illinois. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Recurrence, Lung Cancer and other specialties. Northwestern Medicine Cancer Center Delnor is involved with conducting 174 clinical trials across 363 conditions. There are 47 research doctors associated with this hospital, such as Aparna Kalyan, Sunandana Chandra, Devalingam Mahalingam, MBBChBAO, and Seth M. Pollack.